Establishment of an induced pluripotent cell line (ABCRIi001-A) from an elderly female for ageing research

Filipa Esteves1, David Brito1, Ana Teresa Rajado1

  • 1Algarve Biomedical Center Research Institute (ABC-RI), University of Algarve, Gambelas Campus, Bld. 2, 8005-139 Faro, Portugal; Algarve Biomedical Center (ABC), University of Algarve, Gambelas Campus, Bld. 2, 8005-139 Faro, Portugal.

Stem Cell Research
|October 22, 2024
PubMed

Insights

We generated a new human induced pluripotent stem cell (hiPSC) line, ABCRIi001-A, from an elderly female donor. This valuable cell line can be used for studying age-related diseases and developing aging scores.

Area of Science:

  • Stem cell biology
  • Gerontology
  • Disease modeling

Background:

  • Human induced pluripotent stem cells (hiPSCs) are crucial for disease modeling, particularly for age-related conditions.
  • Understanding the aging process requires robust cellular models derived from elderly individuals.

Purpose of the Study:

  • To generate and characterize a novel hiPSC line from a 79-year-old female donor.
  • To establish a valuable cellular resource for aging research and the development of aging scores.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from an elderly female donor were reprogrammed using Sendai virus vectors (hKOS, hc-Myc, hKlf4).
  • The generated hiPSC line (ABCRIi001-A) underwent rigorous characterization, including morphology, karyotype, viral clearance, and pluripotency assays.

Main Results:

  • The ABCRIi001-A hiPSC line exhibited normal morphology and karyotype.
  • Confirmed viral clearance, absence of genomic aberrations, and successful differentiation into three germ layers.
  • Pluripotency was validated through the expression of key markers.

Conclusions:

  • The ABCRIi001-A hiPSC line is a well-characterized and stable cellular model.
  • This hiPSC line is a valuable resource for investigating human aging mechanisms and diseases.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K